Gonyautoxin 2/3 cutaneous formulation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gonyautoxin 2/3 cutaneous formulation, covering 2008-08-25 to 2008-08-25. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of a Cutaneous Formulation of Gonyautoxin 2/3 (GTX 2/3) for the Treatment of Facial Wrinkles [Phase 1, Phase 2]